Lantheus Archives - Mediformatica

Lantheus Holdings, Inc. celebrates FDA approval for DEFINITY as an ultrasound enhancing agent in pediatric patients with suboptimal echocardiograms. Rigorous clinical trials affirm DEFINITY’s efficacy and safety in this population, marking a significant stride…

Neuralink receives approval to begin clinical trial in Canada on brain implant

Rightway, Curai Health partner to expand access to virtual care

A Remote Patient Monitoring System With Feedback Mechanisms Using a Smartwatch: Concept, Implementation, and Evaluation Based on the activeDCM Randomized Controlled Trial

CommonSpirit partners up with U of U for clinical collaboration

Tag: Lantheus

Lantheus Unlocks Advanced Cancer Care, Bringing Hope

Lantheus Advances Pediatric Cardiovascular Imaging with DEFINITY

Neuralink receives approval to begin clinical trial in Canada on brain implant

A Look at Epic Culture and Interoperability with Brendan Keeler – Part 1

Rightway, Curai Health partner to expand access to virtual care

A Remote Patient Monitoring System With Feedback Mechanisms Using a Smartwatch: Concept, Implementation, and Evaluation Based on the activeDCM Randomized Controlled Trial

CommonSpirit partners up with U of U for clinical collaboration

Twin Brothers Launch Seen Health with $22M to Provide Culturally-Focused Care for Seniors – MedCity News

Converge Bio raises $5.5M to expedite drug discovery, development with GenAI

Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing? – MedCity News

‘A Lot More Teamwork’: Healthcare Explores the Use of AI for Nursing Workflows

Millions of Americans Still Uninsured or Underinsured Despite ACA Gains

MediFormatica

News Aggregator